Literature DB >> 24585456

Re-analysis of the PREGNANT trial confirms that vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix.

L A McKay1, T R Holford, M B Bracken.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24585456     DOI： 10.1002/uog.13331

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN： 0960-7692            Impact factor:   7.299


× No keyword cloud information.
  6 in total

Review 1.  Prenatal administration of progestogens for preventing spontaneous preterm birth in women with a multiple pregnancy.

Authors:  Jodie M Dodd; Rosalie M Grivell; Cecelia M OBrien; Therese Dowswell; Andrea R Deussen
Journal:  Cochrane Database Syst Rev       Date:  2017-10-31

2.  Prenatal administration of progestogens for preventing spontaneous preterm birth in women with a multiple pregnancy.

Authors:  Jodie M Dodd; Rosalie M Grivell; Cecelia M OBrien; Therese Dowswell; Andrea R Deussen
Journal:  Cochrane Database Syst Rev       Date:  2019-11-20

3.  A soft cervix, categorized by shear-wave elastography, in women with short or with normal cervical length at 18-24 weeks is associated with a higher prevalence of spontaneous preterm delivery.

Authors:  Edgar Hernandez-Andrade; Eli Maymon; Suchaya Luewan; Gaurav Bhatti; Mohammad Mehrmohammadi; Offer Erez; Percy Pacora; Bogdan Done; Sonia S Hassan; Roberto Romero
Journal:  J Perinat Med       Date:  2018-07-26       Impact factor: 2.716

4.  The influence of the introduction of national guidelines on preterm birth prevention practice: UK experience.

Authors:  A Care; L Ingleby; Z Alfirevic; A Sharp
Journal:  BJOG       Date:  2018-12-28       Impact factor: 6.531

Review 5.  Vaginal progesterone decreases preterm birth ≤ 34 weeks of gestation in women with a singleton pregnancy and a short cervix: an updated meta-analysis including data from the OPPTIMUM study.

Authors:  R Romero; K H Nicolaides; A Conde-Agudelo; J M O'Brien; E Cetingoz; E Da Fonseca; G W Creasy; S S Hassan
Journal:  Ultrasound Obstet Gynecol       Date:  2016-07-19       Impact factor: 7.299

6.  Progesterone supplementation for HIV-positive pregnant women on protease inhibitor-based antiretroviral regimens (the ProSPAR study): a study protocol for a pilot randomized controlled trial.

Authors:  Kaitlin Siou; Sharon L Walmsley; Kellie E Murphy; Janet Raboud; Mona Loutfy; Mark H Yudin; Michael Silverman; Noor N Ladhani; Lena Serghides
Journal:  Pilot Feasibility Stud       Date:  2016-08-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.